Año: 2022
Journal Impact Factor (JIF): 4.70
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| PHARMACOLOGY & PHARMACY | SCIE | 68/278 | Q1 | T1 | D3 |
| BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | 92/285 | Q2 | T1 | D4 |
| MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | 54/136 | Q2 | T2 | D4 |
Año: 2022
Journal Citation Indicator (JCI): 0,870
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| BIOCHEMISTRY & MOLECULAR BIOLOGY | 94/315 | Q2 | T1 | D3 | 70,32 |
| MEDICINE, RESEARCH & EXPERIMENTAL | 62/190 | Q2 | T1 | D4 | 67,63 |
| PHARMACOLOGY & PHARMACY | 110/366 | Q2 | T1 | D3 | 70,08 |
Año:
2022
CiteScore:
3,700
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Biochemistry, Genetics and Molecular Biology (all) | 93/212 | Q2 | T2 | D5 |
| Medicine (miscellaneous) | 132/309 | Q2 | T2 | D5 |
SJR año:
2022
Factor de Impacto:
0,897
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Medicine (miscellaneous) | 574/2531 | Q1 | T1 | D3 |
| Biochemistry, Genetics and Molecular Biology (miscellaneous) | 75/307 | Q2 | T1 | D3 |
| Agencia | Código de Proyecto |
|---|---|
| - | 2020-1-PL01-KA203-081905 |
| Erasmus + Strategic Partnership for Higher Education Program | - |
| # | Autor |
|---|---|
| 1 | Martin-Vega, Francisco Javier |
| 2 | |
| 3 | Galán-Mercant, Alejandro |
| 4 | Perez-Cabezas, Veronica |
| 5 | Luque-Moreno, Carlos |
| 6 | Viñolo-Gil, Maria Jesus |
| 7 | González-Medina, Gloria |